Clinical trials: Covert Hepatic Encephalopathy
Covert Hepatic Encephalopathy
GELSECTAN® and Covert Hepatic Encephalopathy
Randomized crossover pilot clinical trial in which 10 cirrhotic patients with covert hepatic encephalopathy (CHE) will be assigned to take GELSECTAN® (TID) or placebo for 30 days.
- Trial name
- GELSECTAN (NCT05189834)
- Testing
- Gelsectan
- Where
- Spain
- Sponsor
- Consorci Sanitari de l'Alt Penedès i Garraf
Cirrhosis, Liver, Minimal Hepatic Encephalopathy
Rifaximin's Effect on Covert Hepatic Encephalopathy With SIBO and Gastrointestinal Dysmotility
Small Intestinal Bacterial Overgrowth (SIBO) is a common and increasingly recognized disorder in cirrhosis (30% to 73%). One of the most important predisposing factors of SIBO is small bowel dysmotility.
- Conditions
- Cirrhosis, Liver, Minimal Hepatic Encephalopathy, Small Intestinal Bacterial Overgrowth, Gastrointestinal Motility Disorder
- Trial name
- NCT04244877
- Testing
- Rifaximin
- Sponsor
- MetroHealth Medical Center
Liver Cirrhosis, Hepatic Encephalopathy
Diagnosis of Covert/Minimal Hepatic Encephalopathy by Means of Continuous Reaction Time Measurement
The investigators wish to investigate how the Continuous Reaction Time (CRT) method can be used in the diagnosis and monitoring of covert hepatic encephalopathy (cHE)in patients with cirrhosis of the liver.
- Trial name
- NCT01773538
- Testing
- Lactulose and rifaximin, Branched Chain amino acids
- Where
- 2 sites in Denmark
- Volunteers
- 136 people, healthy volunteers welcome
- Sponsor
- Mette Munk Lauridsen
Covert Hepatic Encephalopathy
Low-dose Rifaximin in the Treatment of Covert Hepatic Encephalopathy
Several studies have been showed that rifaximin can improve cognitive functions, driving simulator performance and health-related quality of life in patients with minimal hepatic encephalopathy.
- Trial name
- NCT03077217
- Testing
- Rifaximin
- Where
- China
- Volunteers
- 40 people
- Sponsor
- Shanghai Changzheng Hospital
Hepatic Encephalopathy, Cirrhosis
iPod Games in Hepatic Encephalopathy
To see if using ipod games can improve mental functioning
- Trial name
- NCT02154282
- Testing
- ipod games
- Where
- United States
- Volunteers
- 30 people
- Sponsor
- Hunter Holmes Mcguire Veteran Affairs Medical Center
Cirrhosis, Hepatic Encephalopathy
HEAL STUDY (Hepatic Encephalopathy and Albumin Study)
Patients with continued cognitive impairment after episodes of HE have few options beyond lactulose and rifaximin in the US. Therefore using IV albumin in a randomized, double-blind, placebo-controlled trial, which could…
- Conditions
- Cirrhosis, Hepatic Encephalopathy, Minimal Hepatic Encephalopathy, Covert Hepatic Encephalopathy
- Trial name
- HEAL (NCT03585257)
- Testing
- 25% IV albumin
- Where
- United States
- Volunteers
- 48 people
- Sponsor
- Hunter Holmes Mcguire Veteran Affairs Medical Center
Hepatic Encephalopathy, Covert Hepatic Encephalopathy
Utility of the Clamping Bean Test (CBT) for Covert Hepatic Encephalopathy Screening
Hepatic encephalopathy is a brain dysfunction caused by liver insufficiency and/or porto-systemic shunt. It manifests as a wide spectrum of neurological or psychiatric abnormalities ranging from subclinical alterations to coma.
- Trial name
- NCT06367127
- Where
- China
- Volunteers
- 200 people, healthy volunteers welcome
- Sponsor
- Shanghai Changzheng Hospital
Cirrhosis, Hepatic Encephalopathy
Eye Movement Testing for Diagnosing Encephalopathy in Patients With Liver Disease
This study involves utilizing a noninvasive computer application (Neurofit) that performs oculometric assessment of dynamic visual processing in patients with liver cirrhosis to see if the presence of advance liver disease…
- Trial name
- NCT04940416
- Testing
- Neurofit (oculometric testing)
- Where
- United States
- Volunteers
- 48 people, healthy volunteers welcome
- Sponsor
- Stanford University
Hepatic Encephalopathy, Covert Hepatic Encephalopathy
Affect of Melatonin on Sleep and Cognition in Cirrhosis
The goal of this clinical trial is to learn the affect of melatonin on sleep, cognitive function, and quality of life (QoL) in patients with cirrhosis and a complication called hepatic encephalopathy (HE).
- Conditions
- Hepatic Encephalopathy, Covert Hepatic Encephalopathy, Cirrhosis, Sleep Disturbances and Insomnia
- Trial name
- SNORE-HE (NCT07046429)
- Testing
- Melatonin tablet 3 mg once daily, Thiamine
- Where
- United States
- Volunteers
- 18 people
- Sponsor
- Weill Medical College of Cornell University